These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33079177)

  • 1. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
    Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
    Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
    Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acromegaly improves quality of life, measured by AcroQol.
    Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
    Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly.
    van der Klaauw AA; Biermasz NR; Hoftijzer HC; Pereira AM; Romijn JA
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):123-8. PubMed ID: 18182092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
    Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
    Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Characteristics, Diagnostic Delays, Treatment Patterns, Treatment Outcomes, Comorbidities, and Treatment Costs of Acromegaly in China: A Nationwide Study.
    Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    Front Endocrinol (Lausanne); 2020; 11():610519. PubMed ID: 33335513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
    Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life after long-term biochemical control of acromegaly.
    Kimball A; Dichtel LE; Yuen KCJ; Woodmansee WW; Haines MS; Nachtigall LB; Swearingen B; Jones P; Tritos NA; Sharpless JL; Kaiser UB; Gerweck A; Miller KK
    Pituitary; 2022 Jun; 25(3):531-539. PubMed ID: 35476257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.
    Roerink SH; Wagenmakers MA; Wessels JF; Sterenborg RB; Smit JW; Hermus AR; Netea-Maier RT
    Pituitary; 2015 Jun; 18(3):366-75. PubMed ID: 24965695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PREDICTORS OF QUALITY OF LIFE IN 165 PATIENTS WITH ACROMEGALY: RESULTS FROM A SINGLE-CENTER STUDY.
    Kreitschmann-Andermahr I; Buchfelder M; Kleist B; Kohlmann J; Menzel C; Buslei R; Kołtowska-Häggsträm M; Strasburger C; Siegel S
    Endocr Pract; 2017 Jan; 23(1):79-88. PubMed ID: 27749131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life.
    Andela CD; Biermasz NR; Kaptein AA; Pereira AM; Tiemensma J
    Growth Horm IGF Res; 2015 Oct; 25(5):219-26. PubMed ID: 26164770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
    Hua SC; Yan YH; Chang TC
    Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
    Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.
    Yoshida K; Fukuoka H; Matsumoto R; Bando H; Suda K; Nishizawa H; Iguchi G; Ogawa W; Webb SM; Takahashi Y
    Pituitary; 2015 Dec; 18(6):876-83. PubMed ID: 26123761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly.
    Wang K; Guo X; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    Eur J Health Econ; 2021 Dec; 22(9):1381-1391. PubMed ID: 33988760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
    T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
    Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.
    Wassenaar MJ; Biermasz NR; Kloppenburg M; van der Klaauw AA; Tiemensma J; Smit JW; Pereira AM; Roelfsema F; Kroon HM; Romijn JA
    Growth Horm IGF Res; 2010 Jun; 20(3):226-33. PubMed ID: 20194043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.
    Wexler T; Gunnell L; Omer Z; Kuhlthau K; Beauregard C; Graham G; Utz AL; Biller B; Nachtigall L; Loeffler J; Swearingen B; Klibanski A; Miller KK
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2471-7. PubMed ID: 19366847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.